Stay updated with breaking news from Isotope Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos National Laboratory for producing alpha-emitting medical radioisotopes intended to target and overpower diseased tissue while sparing the healthy tissue around it.
Technicians John Dyer and T. Dyer use a manipulator arm in a shielded cave in ORNL's Radiochemical Engineering Development Center to separate...
LOS ALAMOS, N.M., March 10, 2021—Improved options for cancer treatment are on the way, thanks to a new system developed at Los Alamos National Laboratory...
Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting Enters into Long-Term Supply Agreement with the National Isotope Development Center of the U.S. Department of Energy Isotope Program ?? -GEN isotope generator, which enables a nimble supply of therapeutic radioisotopes with the power of alpha-particle therapy for cancer CORALVILLE, IA / ACCESSWIRE / February 18, 2021 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision α-particle oncology therapeutics and complementary diagnostic imaging agents, today announc...
Award winning Imaging Technology News (ITN) reaches more than 34,000 radiology, radiation oncology, women's health and nuclear medicine professionals.